Malabsoption syndrome as per harrison notes

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I have comprehensive content from Harrison's 22E. Let me now compile the full answer.

Malabsorption Syndrome - Harrison's Principles of Internal Medicine 22E (2025)

Chapter 336: Disorders of Absorption - Deborah C. Rubin

Definition and Overview

Malabsorption syndromes result from disorders affecting one or more of the three phases of enteral nutrient processing:
  1. Luminal phase - initiated by lingual/gastric lipase, gastric pepsin, and continued in the small bowel by pancreatic enzymes and bile salts
  2. Mucosal phase - mediated by enterocyte brush border enzymes (disaccharidases, enterokinases, peptidases), transporters, and micelle-mediated lipid uptake
  3. Postmucosal phase - nutrients transported into lymphatics (long-chain triglycerides as chylomicrons) or the portal circulation

Steatorrhea

The hallmark of malabsorption is steatorrhea - defined as stool fat excretion >7% of dietary fat.
  • Stool volume/weight is normally <200 mL or <200 g in 24 hours
  • Gold standard: 72-hour stool collection for weight and fecal fat determination
  • Stools are large, bulky, and malodorous
  • Malabsorptive diarrhea is precipitated by eating and resolves or significantly decreases at night - this distinguishes it from secretory diarrheas (e.g., toxigenic E. coli) which continue even during fasting

Classification of Causes (Table 336-1)

I. Inadequate Digestion (Luminal Phase Disorders)

Postgastrectomy states
  • Roux-en-Y gastric bypass or Billroth II anastomosis cause rapid gastric emptying into the jejunum - inadequate mixing with bile and pancreatic secretions
Deficiency/inactivation of pancreatic lipase
  • Exocrine pancreatic insufficiency
  • Chronic pancreatitis
  • Pancreatic carcinoma
  • Cystic fibrosis
  • Gastrinoma (acid inactivation of lipase)
  • Drugs (orlistat)
Reduced intraluminal bile acid / impaired micelle formation
  • Parenchymal liver disease
  • Cholestatic disease (primary sclerosing cholangitis, primary biliary cholangitis)
  • Ileal resection or disease (Crohn's disease)
  • Small bowel bacterial overgrowth

II. Impaired Mucosal Digestion and Absorption (Mucosal Phase Disorders)

  • Celiac disease
  • Whipple's disease
  • Abetalipoproteinemia
  • Lymphoma
  • Radiation enteritis
  • Eosinophilic enteritis
  • Mastocytosis
  • Tropical sprue
  • Graft-versus-host disease
  • Folate and vitamin B12 deficiency
  • Infections - giardiasis
  • Genetic disorders: disaccharidase deficiency, agammaglobulinemia, abetalipoproteinemia, Hartnup's disease, cystinuria

III. Impaired Nutrient Delivery to/from Intestine (Postmucosal Disorders)

Lymphatic obstruction
  • Lymphoma
  • Lymphangiectasia
Circulatory disorders
  • Congestive heart failure
  • Constrictive pericarditis
  • Mesenteric artery atherosclerosis
  • Vasculitis
Endocrine and metabolic disorders
  • Diabetes mellitus
  • Hypoparathyroidism
  • Adrenal insufficiency
  • Hyperthyroidism
  • Carcinoid syndrome

Specific Nutrients

Lipid Absorption

Lipid absorption requires:
  1. Pancreatic enzymes and bile salts for hydrolysis and physicochemical dispersion
  2. Absorption of lipids dispersed in bile salt-mixed micelles across intestinal epithelium
  3. Re-esterification to triglycerides in enterocytes and packaging into chylomicrons
  4. Secretion into lymphatics (too large for capillaries)

Carbohydrate Absorption

  • Digestion by salivary amylase, pancreatic amylase, and brush border disaccharidases (lactase, sucrase-isomaltase)
  • Products absorbed via specific transporters

Protein Absorption

  • Digested by gastric pepsin and pancreatic proteases (trypsin, chymotrypsin)
  • Brush border peptidases produce dipeptides, tripeptides, and amino acids absorbed via specific transporters

Disorders That Affect the Luminal Phase

Gastric Resection

Procedures like Roux-en-Y or Billroth II result in rapid gastric emptying, leading to diarrhea and weight loss from inadequate mixing with biliary and pancreatic secretions.

Disordered Intestinal Motility

  • Hyperthyroidism: increased intestinal motility - inadequate mixing with pancreatic/biliary secretions
  • Diabetes mellitus: enteric neuropathy causes either increased motility/diarrhea or reduced motility/constipation
  • Scleroderma: affects intestinal smooth muscle profoundly

Pancreatic Disorders

Chronic pancreatitis causes marked reduction in pancreatic enzyme secretion. Features:
  • Steatorrhea (voluminous, bulky, malodorous stools)
  • Deficiency of fat-soluble vitamins: A, E, D (most commonly), and K
  • Weight loss

Bile Salt Deficiency

  • Hepatobiliary disease: decreased bile acid synthesis (hepatocyte dysfunction) or reduced secretion (bile duct disease)
  • Ileal resection/disease:
    • <100 cm resection: bile acid spillage into colon → secretory diarrhea; responds to cholestyramine
    • 100 cm resection: loss exceeds liver synthetic capacity → fat malabsorption dominates (>20 g steatorrhea); responds to low-fat diet

Small Bowel Bacterial Overgrowth (SIBO)

Results in luminal bile acid deficiency due to bacterial deconjugation of bile salts.

Mucosal Phase Disorders

Lactase Deficiency

The most common brush border enzyme deficiency:
  • Primary (adult-type hypolactasia): autosomal recessive; absence of LCT-13910 "persistence" allele
  • Secondary: viral, bacterial, or parasitic infections; intestinal mucosal diseases
  • Mechanism: undigested lactose acts as osmotic substance drawing fluid into the lumen; colonic bacteria ferment lactose producing H₂, CO₂, methane, causing bloating and pain
  • Symptoms: diarrhea, abdominal pain, gassiness, bloating after dairy ingestion

Celiac Disease (Celiac Sprue / Gluten-Sensitive Enteropathy)

Definition: Small-intestinal enteropathy from immune response to gluten (wheat, rye, barley, some oats), characterized by autoantibodies to tissue transglutaminase (TTG).
Epidemiology: Global prevalence 1.4%; US seroprevalence ~1.0% in white populations; prevalence 10-15% in first-degree relatives.
Genetics: HLA-DQ2 and DQ8 required (but not sufficient); present in 25-35% of the general population; negative test has NPV >99% for ruling out celiac disease.
Presentation:
  • Diarrhea, weight loss, growth failure in children
  • Isolated iron-deficiency anemia (duodenal disease)
  • Bloating, irregular bowel habits, migraine headaches, ataxia
  • Osteoporosis, abnormal liver enzymes
  • Proximal small intestine primarily affected
Mechanism of diarrhea: Villus atrophy → steatorrhea from mucosal malabsorption; crypt hyperplasia → fluid hypersecretion (secretory component); secondary lactase deficiency
Associated diseases: Type 1 diabetes, autoimmune thyroid disease, dermatitis herpetiformis (IgA deposits in skin, vesicular rash), Down syndrome, Turner syndrome
Diagnosis:
  1. Screening: TTG-IgA (test of choice) + serum IgA level (to detect false negatives from IgA deficiency)
  2. If IgA deficient: TTG-IgG or anti-deamidated gliadin peptide (DGP-IgG)
  3. Confirmation: Endoscopy with small-intestinal biopsy showing villus blunting, crypt hyperplasia
Treatment: Gluten-free diet (wheat, rye, barley avoided)

Postmucosal Phase Disorders

Intestinal Lymphangiectasia

Primary or secondary damage to intestinal lymphatics:
  • Primary: congenital or acquired; intrinsic lymphatic dysfunction
  • Secondary: retroperitoneal fibrosis, fibrosing mesenteritis, lymphoma, Fontan physiology, constrictive pericarditis, congestive heart failure
  • Result: malabsorption + protein-losing enteropathy

Protein-Losing Enteropathy

Hypoproteinemia + edema in absence of liver disease or renal proteinuria. Three categories:
  1. Mucosal ulceration (exudation across damaged mucosa): ulcerative colitis, GI carcinomas
  2. Non-ulcerated mucosa with altered permeability: celiac disease, Ménétrier's disease
  3. Lymphatic dysfunction: primary lymphatic disease or secondary obstruction (enlarged nodes, cardiac disease)
Diagnosis: Low serum albumin AND globulins; alpha-1 antitrypsin in stool (elevated = diagnostic; must use clearance method for accuracy); lymphopenia (loss of CD3+ T cells via lymphatics) indicates GI protein loss.
Note: Selective albumin loss with normal globulins → renal/hepatic disease; Selective globulin loss with normal albumin → reduced synthesis, not GI loss.

Clinical Manifestations of Malabsorption (Table 336-5)

Symptom/SignMechanism
Weight loss/malnutritionAnorexia, malabsorption of nutrients
DiarrheaImpaired absorption/secretion of water and electrolytes; colonic fluid secretion secondary to unabsorbed dihydroxy bile acids and fatty acids
FlatusBacterial fermentation of unabsorbed carbohydrate
Glossitis, cheilosis, stomatitisDeficiency of iron, vitamin B12, folate, vitamin A
Abdominal painBowel distention or inflammation, pancreatitis
Bone painCalcium/vitamin D malabsorption, protein deficiency, osteoporosis
Tetany, paresthesiaCalcium and magnesium malabsorption
WeaknessAnemia, electrolyte depletion (particularly K+)
Azotemia, hypotensionFluid and electrolyte depletion
Amenorrhea, decreased libidoProtein depletion, decreased calories, secondary hypopituitarism
AnemiaImpaired absorption of iron, folate, vitamin B12
BleedingVitamin K malabsorption, hypoprothrombinemia
Night blindness/xerophthalmiaVitamin A malabsorption
Peripheral neuropathyVitamin B12, thiamine, vitamin E, pyridoxine, niacin deficiency
DermatitisDeficiency of vitamin A, zinc, essential fatty acid

Evaluation of the Patient with Suspected Malabsorption

History

Key questions include:
  • Abdominal pain, diarrhea, weight loss, bloating
  • Signs of selective nutrient deficiency: iron-deficiency anemia, bone fractures/osteoporosis (vitamin D/calcium), peripheral neuropathy (B12), hair loss (protein deficiency)
  • Predisposing disorders: chronic pancreatitis, liver/biliary disease (primary biliary cholangitis, primary sclerosing cholangitis)
  • History of small-bowel resection (Crohn's disease, trauma, ischemia)
  • Travel history (tropical sprue, giardiasis)

Physical Examination

  • Bitemporal wasting and reduced arm circumference - significant weight loss
  • Nail spooning - iron deficiency
  • Peripheral neuropathy (sensory reduction, tingling, numbness) - vitamin B12 deficiency

Diagnostic Tests

  • 72-hour stool collection for fecal fat: gold standard for steatorrhea
  • Serum TTG-IgA for celiac disease screening
  • Serum IgA level
  • Alpha-1 antitrypsin clearance for protein-losing enteropathy
  • Serum albumin, globulins
  • CBC (anemia, lymphopenia)
  • Serum B12, folate, iron studies, vitamins D, A, E, K (PT/INR)

Source: Harrison's Principles of Internal Medicine 22E (2025, McGraw Hill Medical), Chapter 336 - Disorders of Absorption
This is a shared conversation. Sign in to Orris to start your own chat.